Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.
about
Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@en
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@nl
type
label
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@en
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@nl
prefLabel
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@en
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@nl
P2093
P2860
P1433
P1476
Plasma alpha-1-acid glycoprote ...... xel in breast cancer patients.
@en
P2093
Gwo Fuang Ho
Muhammad Azrif Bin Ahmad Annuar
Rafid Salim Jabir
P2860
P304
P356
10.1080/1354750X.2017.1334152
P50
P577
2017-05-30T00:00:00Z